Evonik launches updated Biolys product for animal feeds
The new Biolys provides higher concentration of L-lysine
The new Biolys provides higher concentration of L-lysine
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
 
        Subscribe To Our Newsletter & Stay Updated